Literature DB >> 18367203

Length of the QT interval: determinants and prognostic implications in a population-based prospective study of older men.

Syed Mohammad Afzal Sohaib1, Olia Papacosta, Richard W Morris, Peter W Macfarlane, Peter H Whincup.   

Abstract

OBJECTIVE: We examined potential determinants and prognostic value of the corrected QT interval (QTc).
DESIGN: A total of 4252 British men aged 60 to 79 years had a resting 12-lead electrocardiogram. Potential determinants of the QTc were assessed using multivariable regression. Men were followed up for 7 years.
RESULTS: A 1 standard deviation increase in QTc (26 milliseconds) was associated with increased all-cause mortality (hazard ratio, 1.13; 95% confidence interval, 1.05-1.22). Longer QTc was associated with increasing age, preexisting coronary heart disease, and a range of drugs. Shorter QTc was present in diabetics and smokers. Corrected QT interval was related inversely with serum potassium and calcium and positively with serum urate, sodium, and systolic blood pressure. The relation of QTc to all-cause mortality was independent of adjustment for these factors.
CONCLUSIONS: Age, preexisting coronary heart disease, certain medications and biochemical factors, and diabetes are independently associated with QTc. Corrected QT interval is an independent predictor of all-cause mortality.

Entities:  

Mesh:

Year:  2008        PMID: 18367203     DOI: 10.1016/j.jelectrocard.2008.01.010

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  21 in total

1.  Comparison of the effects of levofloxacin on QT/QTc interval assessed in both healthy Japanese and Caucasian subjects (pages.

Authors:  Atsushi Sugiyama; Yuji Nakamura; Satomi Nishimura; Satomi Adachi-Akahane; Yuji Kumagai; Juleen Gayed; Asif Naseem; Georg Ferber; Jorg Taubel; John Camm
Journal:  Br J Clin Pharmacol       Date:  2012-03       Impact factor: 4.335

2.  Development of a risk model for predicting QTc interval prolongation in patients using QTc-prolonging drugs.

Authors:  Anita N Bindraban; José Rolvink; Florine A Berger; Patricia M L A van den Bemt; Aaf F M Kuijper; Ruud T M van der Hoeven; Aukje K Mantel-Teeuwisse; Matthijs L Becker
Journal:  Int J Clin Pharm       Date:  2018-07-26

3.  Electrocardiographic QT interval and mortality: a meta-analysis.

Authors:  Yiyi Zhang; Wendy S Post; Elena Blasco-Colmenares; Darshan Dalal; Gordon F Tomaselli; Eliseo Guallar
Journal:  Epidemiology       Date:  2011-09       Impact factor: 4.822

Review 4.  Risk factors for QTc-prolongation: systematic review of the evidence.

Authors:  Eline Vandael; Bert Vandenberk; Joris Vandenberghe; Rik Willems; Veerle Foulon
Journal:  Int J Clin Pharm       Date:  2016-12-23

5.  Association of QT-Prolonging Medication Use in CKD with Electrocardiographic Manifestations.

Authors:  Soren Snitker; Rebecca M Doerfler; Elsayed Z Soliman; Rajat Deo; Wendy L St Peter; Susan Kramlik; Michael J Fischer; Sankar Navaneethan; Patrice Delafontaine; Bernard G Jaar; Akinlolu Ojo; Gail K Makos; Anne Slaven; Matthew R Weir; Min Zhan; Jeffrey C Fink
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-09       Impact factor: 8.237

6.  QT-interval duration and mortality rate: results from the Third National Health and Nutrition Examination Survey.

Authors:  Yiyi Zhang; Wendy S Post; Darshan Dalal; Elena Blasco-Colmenares; Gordon F Tomaselli; Eliseo Guallar
Journal:  Arch Intern Med       Date:  2011-10-24

7.  Risk factors for QTc interval prolongation.

Authors:  Charlotte P M Heemskerk; Marieke Pereboom; Karlijn van Stralen; Florine A Berger; Patricia M L A van den Bemt; Aaf F M Kuijper; Ruud T M van der Hoeven; Aukje K Mantel-Teeuwisse; Matthijs L Becker
Journal:  Eur J Clin Pharmacol       Date:  2017-11-22       Impact factor: 2.953

8.  Hyperglycemia is associated with corrected QT prolongation and mortality in acutely ill patients.

Authors:  David Pickham; Elena Flowers; Barbara J Drew
Journal:  J Cardiovasc Nurs       Date:  2014 May-Jun       Impact factor: 2.083

9.  Different body parts' fat mass and corrected QT interval on the electrocardiogram: The Fasa PERSIAN Cohort Study.

Authors:  Mohammad Hosein Yazdanpanah; Ehsan Bahramali; Mohammad Mehdi Naghizadeh; Mojtaba Farjam; Maryam Mobasheri; Shiva Dadvand
Journal:  BMC Cardiovasc Disord       Date:  2021-06-05       Impact factor: 2.298

10.  Adult height and incidence of atrial fibrillation and heart failure in older men: The British Regional Heart Study.

Authors:  S Goya Wannamethee; Olia Papacosta; Lucy Lennon; Aroon Hingorani; Peter Whincup
Journal:  Int J Cardiol Heart Vasc       Date:  2021-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.